BiVictriX Therapeutics plc (AIM:BVX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
10.00
+1.50 (17.65%)
Inactive · Last trade price on Sep 10, 2024

BiVictriX Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
891120--
Upgrade
Market Cap Growth
4.02%-22.90%-42.37%---
Upgrade
Enterprise Value
77720--
Upgrade
Last Close Price
0.100.100.170.29--
Upgrade
PE Ratio
--3.00-4.50-4.90--
Upgrade
PB Ratio
3.582.452.843.08--
Upgrade
P/FCF Ratio
--4.41-4.03-10.65--
Upgrade
P/OCF Ratio
--4.42-4.69-10.93--
Upgrade
EV/EBITDA Ratio
--2.42-2.37-13.33--
Upgrade
EV/EBIT Ratio
--2.37-2.33-13.18--
Upgrade
EV/FCF Ratio
-3.19-3.65-2.49-10.81--
Upgrade
Debt / Equity Ratio
0.090.070.070.0410.01-
Upgrade
Debt / FCF Ratio
-0.10-0.13-0.11-0.13-2.93-
Upgrade
Quick Ratio
4.405.989.8516.683.023.05
Upgrade
Current Ratio
4.406.1210.1417.263.053.08
Upgrade
Return on Equity (ROE)
-103.99%-67.92%-48.56%-73.19%-344.13%-166.94%
Upgrade
Return on Assets (ROA)
-62.99%-42.82%-32.57%-23.62%-48.82%-107.08%
Upgrade
Return on Capital (ROIC)
-70.51%-46.97%-34.35%-25.68%-70.94%-134.18%
Upgrade
Earnings Yield
-35.21%-29.37%-22.22%-12.00%--
Upgrade
FCF Yield
-25.71%-22.68%-24.79%-9.39%--
Upgrade
Buyback Yield / Dilution
-14.81%-9.88%-70.11%-72.66%-23419.58%-17.33%
Upgrade
Total Shareholder Return
-14.81%-9.88%-70.11%-72.66%-23419.58%-17.33%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.